Multiple system atrophy (MSA) is a progressive disorder with limited treatment options. However, recent research has yielded potential insights into new therapeutic approaches. Current research centers on addressing the underlying pathophysiology of MSA. One strategy under investigation involves pharmacological interventions to influence the funct